The effect of diffuse pulmonary fibrosis on the reliability of CT signs of pulmonary hypertension

Radiology

Volumn 249, Issue 3, 2008, Pages 1042-1049

  Devaraj, Anand ^a   Wells, Athol U ^a   Meister, Mark G ^a   Corte, Tamera J ^a   Hansell, David M ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTERY DILATATION; ARTICLE; ASCENDING AORTA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FIBROSING ALVEOLITIS; HEART CATHETERIZATION; HUMAN; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; TOTAL LUNG CAPACITY; ADOLESCENT; AORTOGRAPHY; BLOOD PRESSURE; LUNG FIBROSIS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIOGRAPHY; VASCULAR RESISTANCE;

ADOLESCENT; ADULT; AGED; AORTOGRAPHY; BLOOD PRESSURE; FEMALE; HEART CATHETERIZATION; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PULMONARY ARTERY; PULMONARY FIBROSIS; TOMOGRAPHY, X-RAY COMPUTED; TOTAL LUNG CAPACITY; VASCULAR RESISTANCE;

EID: 58149192363     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2492080269     Document Type: Article

References (33)

1. King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001;164:1171-1181.
2. Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006;129:746-752.
3. Nadrous HF, Pellikka PA, Krowka MJ, et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest 2005;128:2393-2399.
4. Shorr AF, Wainright JL, Cors CS, Lettieri CJ, Nathan SD. Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur Respir J 2007;30:715-721.
5. Hamada K, Nagai S, Tanaka S, et al. Significance of pulmonary arterial pressure anddiffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 2007;131:650-656.
6. Arcasoy SM, Christie JD, Ferrari VA, et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003;167:735-740.
7. Haimovici JB, Trotman-Dickenson B, Halpern EF, et al. Relationship between pulmonary artery diameter at computed tomography and pulmonary artery pressures at right-sided heart catheterization: Massachusetts General Hospital Lung Transplantation Program. Acad Radiol 1997;4:327-334.
8. Kuriyama K, Gamsu G, Stern RG, Cann CE, Herfkens RJ, Brundage BH. CT-determined pulmonary artery diameters in predicting pulmonary hypertension. Invest Radiol 1984;19:16-22.
9. Ng CS, Wells AU, Padley SP. A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter. J Thorac Imaging 1999;14:270-278.
10. Zisman DA, Karlamangla AS, Ross DJ, et al. High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest 2007;132:773-779.
11. American Thoracic Society (ATS), European Respiratory Society (ERS). ATS/ERS International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias: this joint statement of the ATS, and the ERS was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;165:277-304. [Published correction appears in Am J Respir Crit Care Med 2002;166:426.]
12. Lacasse Y, Selman M, Costabel U, et al. Clinical diagnosis of hypersensitivity pneumonitis. Am J Respir Crit Care Med 2003;168:952-958.
13. Cook LB, Morgan M. Pulmonary artery catheterisation. Ann Acad Med Singapore 1994;23:519-530.
14. Cholley BP, Payen D. Noninvasive techniques for measurements of cardiac output. Curr Opin Crit Care 2005;11:424-429.
15. Mazza E, Taichman DB. Functions and control of the pulmonary circulation. In: Mandel J, Taichman D, eds. Pulmonary vascular disease. Philadelphia, Pa: Saunders Elsevier, 2006; 1-19.
16. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known: 1916. Nutrition 1989;5:303-311.
17. Edwards PD, Bull RK, Coulden R. CT measurement of main pulmonary artery diameter. Br J Radiol 1998;71:1018-1020.
18. Gay SE, Kazerooni EA, Toews GB, et al. Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am J Respir Crit Care Med 1998;157:1063-1072.
19. Desai SR, Veeraraghavan S, Hansell DM, et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology 2004;232:560-567.
20. Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariable methods. 2nd ed. Boston, Mass: PWS-Kent, 1988.
21. Dupuis J, Hoeper MM. Endothelin receptor antagonists in pulmonary arterial hypertension. Eur Respir J 2008;31:407-415.
22. McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004;126(suppl 1):S14-S34.
23. Perez-Enguix D, Morales P, Tomas JM, Vera F, Lloret RM. Computed tomographic screening of pulmonary arterial hypertension in candidates for lung transplantation. Transplant Proc 2007;39:2405-2408.
24. Tan RT, Kuzo R, Goodman LR, Siegel R, Haasler GB, Presberg KW. Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease: Medical College of Wisconsin Lung Transplant Group. Chest 1998;113:1250-1256.
25. Nava S, Rubini F. Lung and chest wall mechanics in ventilated patients with end stage idiopathic pulmonary fibrosis. Thorax 1999;54:390-395.
26. Chang SM, Lin CC, Hsiao SH, et al. Pulmonary hypertension and left heart function: insights from tissue Doppler imaging and myocardial performance index. Echocardiography 2007;24:366-373.
27. Turner-Warwick M. Precapillary systemic-pulmonary anastomoses. Thorax 1963;18:225-237.
28. Wells AU, Hansell DM, Rubens MB, Cailes JB, Black CM, du Bois RM. Functional impairment in lone cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a comparison. Am J Respir Crit Care Med 1997;155:1657-1664.
29. Cudkowicz L, Calabresi M, Nims RG, Gray FD Jr. The simultaneous estimation of right and left ventricular outputs applied to a study of the bronchial circulation in patients with chronic lung disease. Am Heart J 1959;58:743-749.
30. Nathan SD, Noble PW, Tuder RM. Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots. Am J Respir Crit Care Med 2007;175:875-880.
31. Patel NM, Lederer DJ, Borczuk AC, Kawut SM. Pulmonary hypertension in idiopathic pulmonary fibrosis. Chest 2007;132:998-1006.
32. Rubin LJ. Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004;126(suppl 1):S7-S10.
33. Shigemitsu H, Nagai S, Sharma OP. Pulmonary hypertension and granulomatous vasculitis in sarcoidosis. Curr Opin Pulm Med 2007;13:434-438.